Where AJIPHASE™ Is Made
Two cGMP facilities — Tokai, Japan and Wetteren, Belgium — offer geographic and regulatory redundancy for global programs requiring AJIPHASE™ capacity.
AJIPHASE PRODUCTION
Tokai, Japan
Japan serves as the center for AJIPHASE™ process development, analytical development, technology transfer, and cGMP manufacturing. Integrated development, quality, and manufacturing teams support programs from early development through commercial supply.
Flow Chemistry
Wettern, Belgium
Belgium provides cGMP peptide manufacturing capabilities using AJIPHASE™, conventional liquid-phase synthesis, and flow chemistry technologies. The site supports commercial production, scale-up, and long-term supply of peptide therapeutics.
AJIPHASE PRODUCTION
Tokai, Japan
Japan serves as the center for AJIPHASE™ process development, analytical development, technology transfer, and cGMP manufacturing. Integrated development, quality, and manufacturing teams support programs from early development through commercial supply.
Flow Chemistry
Wettern, Belgium
Belgium provides cGMP peptide manufacturing capabilities using AJIPHASE™, conventional liquid-phase synthesis, and flow chemistry technologies. The site supports commercial production, scale-up, and long-term supply of peptide therapeutics.